The ISPPD Board is gratified to announce Professor Kim Mulholland as the Robert Austrian Lecturer for ISPPD-11.
Professor Mulholland is an Australian paediatrician with a strong background in tropical medicine and immunology. He led multiple research studies and programmes in developing countries, including the Philippines and the Gambia. Between 1995 and 2000 Professor Mulholland worked at the World Health Organization (WHO), where he was responsible for the development of clinical research programmes in the field of childhood pneumonia, development of bacterial vaccines against meningitis and pneumonia in developing countries. After working at the WHO, he returned to Melbourne where he established a comprehensive pneumococcal research programme for Asia-Pacific region. In the last decade, Professor Mulholland has led this programme located at the Menzies School of Health Research in Darwin and Murdoch Children's Research Institute. In addition, since 2005 Professor Mulholland has also held a position at the London School of Hygiene and Tropical Medicine. In this capacity, he supports research studies in Africa.
Professor Mulholland's contributions to the pneumococcal field are characterized by his innovative and persistent attack on childhood pneumonia, including important improvements in diagnosis, treatment, vaccination, awareness and prevention of pneumonia in children in low and middle-income countries.
Professor Mulholland led the Haemophilus influenzae type B vaccine research program conducted studies in the Gambia on the aetiology of pneumonia in malnourished children and contributed to a multicentre study of the causes of sepsis in children during their first three months of life. In addition, he conducted an efficacy trial in the Gambia to demonstrate the efficacy of one of the Hib conjugate vaccines. He was the first to demonstrate the impact of Hib conjugate vaccines in preventing pneumonia in addition to preventing invasive Hib disease. Also, he conducted a trial of different antibiotics in malnourished children with pneumonia and he has undertaken studies of optimum methods of administering oxygen in the Gambia and in Ethiopia. In addition, he has contributed to the development of standardised definitions of clinical pneumonia and radiological pneumonia, and defined optimum methods for the detection of pneumococcal carriage and economic evaluation of the impact of pneumococcal vaccines. In the last two decades, Professor Mulholland has successfully established a pneumococcal immunology laboratory able to conduct serology to a very high standard and undertake more detailed immunological assays, and a pneumococcal microbiology laboratory which is undertaking important research on the most effective methods of detecting pneumococcal carriage. Further, Professor Mulholland has provided support and continues contributing in many ways to pneumococcal vaccine trials undertaken in the Asia-Pacific, the Gambia, South Africa, Kenya, the USA and Australia. Professor Mulholland has made many important contributions to the prevention of pneumococcal diseases and pneumonia more generally in the developing world, work which has and continues to contribute to a reduction in death and severe illness in young children.
Professor Mulholland has published over 200 papers in peer reviewed journals, contributed to six chapters to books on respiratory infections and he has co-published a book on childhood pneumonia with a focus on the impact of this condition in the developing world.
The Robert Austrian Lecture will be delivered at ISPPD-11 in Melbourne, Australia on Wednesday, April 18, 2018 at 16:00 hrs.
Previous ISPPD Lecturers include :
Helena Mäkelä †, 2002
Brian Greenwood, 2004
Mathu Santosham, 2006
Alexander Tomasz, 2008
Ron Dagan, 2010
Keith Klugman, 2012
Katherine O'Brien, 2014
Marc Lipsitch, 2016